Weyer Christian 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Aug 31, 2020
Insider Transaction Report
Form 4
Weyer Christian
EVP Research and Development
Transactions
- Tax Payment
Common Stock
2020-08-27$48.81/sh−357$17,425→ 16,380 total
Footnotes (1)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.